Chk1 inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers.

Autor: Bryant, Christopher (AUTHOR), Rawlinson, Rebecca (AUTHOR), Massey, Andrew J (AUTHOR)
Zdroj: BMC Cancer. 2014, Vol. 14 Issue 1, p570-570. 1p.
Databáze: Academic Search Ultimate